Position in LLY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$853,994
+$119,098 QoQ
Shares Held
712
-10.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#3,279
of 4,605 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Revisor Wealth Management LLC holds $7,877,632 across 8 Drug Manufacturers - General names. LLY ranks #5 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
|
30,786 | $1,613,802 | |
| 2 | JNJ |
Johnson & Johnson
|
5,622 | $1,427,819 | |
| 3 | AMGN |
Amgen Inc
|
3,075 | $1,113,519 | |
| 4 | ABBV |
AbbVie Inc.
|
3,399 | $855,324 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
712 | $853,994 | |
| 6 | MRK |
Merck & Co., Inc.
|
5,906 | $758,921 | |
| 7 | PFE |
Pfizer Inc
|
30,193 | $727,047 | |
| 8 | NVS |
Novartis AG
|
3,364 | $527,206 |
All Filings in LLY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $853,994 | 712 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $734,896 | 799 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $923,150 | 859 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $583,695 | 765 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $556,584 | 714 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $530,234 | 642 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $545,804 | 707 | Shares | Sole | 2025-02-20 | |
| 2024-09-30 | $1,049,838 | 1,185 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,040,281 | 1,149 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,510,797 | 1,942 | Shares | Sole | 2024-04-23 | |
| No filing history on record for this holder in this stock. | ||||||